Best Oral GLP-1 Tablet & ODT Providers in 2026 — Ranked & Reviewed
Most compounded GLP-1 providers ship injectable vials, but a growing minority offer oral formulations — sublingual tablets, oral dissolving tablets (ODT), or other non-injectable delivery. The clinical evidence for oral compounded GLP-1s is weaker than for the FDA-approved injectable equivalents (no STEP-or-SURMOUNT-equivalent randomized trials of oral compounded semaglutide or tirzepatide), and the only FDA-approved oral GLP-1 for weight loss is Lilly's Foundayo (orforglipron), which is a completely different small-molecule chemistry. That said, ODTs and oral tablets are a reasonable option for needle-averse patients willing to accept the weaker evidence base. Below we rank every provider in our directory offering an oral compounded GLP-1 alongside or instead of injectable versions, with explicit notes on form factor and evidence quality.
Lowest verified price: $7.29/mo92 providers compared
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
92 oral glp-1 tablet & odt providers compared · independently scored against our six-factor methodology.
Compare the top providers at a glance
Logos, our editorial rating, price, medications, and coverage — the fastest way to narrow the list.
- ★ Editor's Pick
the most authoritative brand-name GLP-1 channel, with same-day delivery
From /mo$25Coverage50 statesMedicationsOrforglipron - Best Budget
the cheapest legal brand-name GLP-1
From /mo$25Scales with doseCoverage50 statesMedicationsOrforglipron mainstream telehealth GLP-1 access
From /mo$149CoverageCheck intakeMedicationsSemaglutideTirzepatideOrforglipronoral-lozenge compounded GLP-1 access
From /mo$99Coverage49 statesMedicationsSemaglutideTirzepatide- Best Care Team
year-long coaching wrap around insured branded GLP-1s
From /mo$25Coverage50 statesMedicationsSemaglutide - Nationwide Coverage
Science-forward GLP-1 and peptide care, flat-rate dosing, built-in follow-up
From /mo$170Coverage50 statesMedicationsSemaglutideTirzepatide self-pay brand-name Foundayo and Zepbound KwikPen at retail pharmacies
From /mo$149Scales with doseCoverage50 statesMedicationsOrforglipronTirzepatidelow flat-rate compounded GLP-1 pricing at every dose
From /mo$79Coverage50 statesMedicationsSemaglutideTirzepatide
| Provider | Rating | From /mo | Medications | Coverage | |
|---|---|---|---|---|---|
★ Editor's Pick the most authoritative brand-name GLP-1 channel, with same-day delivery | $25 | Orforglipron | 50 states | Visit → | |
Best Budget the cheapest legal brand-name GLP-1 | $25 Scales by dose | Orforglipron | 50 states | Visit → | |
 mainstream telehealth GLP-1 access | $149 | SemaglutideTirzepatideOrforglipron | Check intake | Visit → | |
 oral-lozenge compounded GLP-1 access | $99 | SemaglutideTirzepatide | 49 states | Visit → | |
Best Care Team year-long coaching wrap around insured branded GLP-1s | $25 | Semaglutide | 50 states | Visit → | |
Nationwide Coverage Science-forward GLP-1 and peptide care, flat-rate dosing, built-in follow-up | $170 | SemaglutideTirzepatide | 50 states | Visit → | |
 self-pay brand-name Foundayo and Zepbound KwikPen at retail pharmacies | $149 Scales by dose | OrforglipronTirzepatide | 50 states | Visit → | |
 low flat-rate compounded GLP-1 pricing at every dose | $79 | SemaglutideTirzepatide | 50 states | Visit → |
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
Detailed Reviews
Amazon One Medical
Best for: the most authoritative brand-name GLP-1 channel, with same-day delivery
Amazon One Medical is the unified Amazon GLP-1 channel — One Medical clinicians prescribe FDA-approved Wegovy, Zepbound, and Foundayo (no compounded products), and Amazon Pharmacy fulfills with same-day delivery across roughly 3,000 US cities plus pickup kiosks at select One Medical locations. No prior membership required; insurance and cash pay both accepted. Foundayo launched at $25/month with insurance and the Lilly Savings Card, or $149/month cash pay.
Score Breakdown
Pros
- ✓As low as $1/day ($25/month) for brand-name Foundayo with insurance and the auto-applied Lilly coupon
- ✓Same-day delivery in nearly 3,000 US cities at launch, expanding to 4,500 by end of 2026
- ✓In-office pharmacist kiosks at select One Medical clinics let you walk out with Foundayo in hand
- ✓Cash-pay $5/day ($149/month) is competitive for the same FDA-approved brand-name product
- ✓Real-time availability, transparent pricing, and automatic manufacturer coupon at checkout
- ✓Delivering GLP-1 medications since 2021 — track record on cold-chain logistics
Cons
- ✗Headline $25/month needs both insurance and the Lilly Savings Card — uninsured pay $149/month
- ✗Same-day delivery is geographically gated; outside major cities it drops to next-day or slower
- ✗Pricing is set by manufacturer savings programs and can change at any time
- ✗No compounded options — brand-name only (Foundayo, Wegovy, Zepbound)
- ✗Wegovy/Zepbound pricing isn't shown upfront — depends on insurance at the prescribing visit
- ✗Copays and deductibles still apply to the clinical visit
LillyDirect Foundayo
Best for: the cheapest legal brand-name GLP-1
Eli Lilly's manufacturer direct-pay channel for Foundayo (orforglipron), the first oral GLP-1 pill for weight loss. With the Lilly Savings Card, commercially insured patients pay $25/month; cash-pay patients pay $149-$299/month depending on labeled dose. Requires a valid US prescription from any licensed prescriber.
Score Breakdown
Pros
- ✓Cheapest legal path to a brand-name GLP-1 in 2026 ($25/mo with savings card for commercial insurance)
- ✓Direct from manufacturer — no compounding, no third-party reseller
- ✓Daily oral pill, no injections, no refrigeration
- ✓Available in all 50 states
Cons
- ✗Lower mean weight loss vs Wegovy (14.9%) and Zepbound (20.9%) — labeled-dose 11.1% per Foundayo PI
- ✗Requires existing prescription from a separate prescriber (LillyDirect does not write the prescription)
- ✗$25 savings card requires commercial insurance — Medicare and Medicaid not eligible
- ✗Strict empty-stomach 30-minute window may be hard for some patients to follow
ShedRx
Verified partnerBest for: mainstream telehealth GLP-1 access
Telehealth provider offering compounded GLP-1 medications in injectable, lozenge, and drop formats.
Score Breakdown
Pros
- ✓Both semaglutide and tirzepatide available
- ✓Compounded GLP-1 access
- ✓Multiple administration formats
Cons
- ✗Limited public information on program details
Strut Health
Verified partnerBest for: oral-lozenge compounded GLP-1 access
Strut Health offers LegitScript + ACHC-accredited compounded semaglutide and tirzepatide in both injectable and oral lozenge formats, shipping to 49 states. Board-certified US physicians handle prescribing with free unlimited follow-up messaging, but eligibility is gated behind a 'medical necessity' clinician determination that isn't publicly defined.
Score Breakdown
Pros
- ✓Both LegitScript and ACHC accredited — pharmacy oversight most compounded GLP-1 providers don't carry
- ✓Oral lozenge option for semaglutide ($99/mo) and tirzepatide ($199/mo) — an injection-free alternative
- ✓Auto-refill pricing saves 13–21% vs one-off orders
- ✓Free unlimited follow-up messaging with board-certified US physicians
- ✓Ships to 49 states (only Arkansas excluded)
Cons
- ✗Requires a "medical necessity" review, but the criteria aren't published — you can't self-screen before paying for a consult
- ✗Compounded only — no FDA-approved Ozempic, Wegovy, Zepbound, or Mounjaro
- ✗Pharmacy partners aren't named — you can't verify the compounding source
- ✗No insurance accepted — cash pay only
- ✗Phone consultation requirement varies by state
Calibrate Health
Best for: year-long coaching wrap around insured branded GLP-1s
Calibrate Health is a year-long metabolic-reset program pairing branded GLP-1 medication (Wegovy, Ozempic, Zepbound, or Foundayo) with 1:1 video coaching and dietitian support — a deeper clinical wrap than transactional telehealth. It's branded-only, with a money-back guarantee tied to outcomes. The $199/month program fee runs separately from medication, which can drop to about $25/month with insurance and a savings card.
Score Breakdown
Pros
- ✓Year-long program with 1:1 video coaching, dietitian support, and behavior-change curriculum — a deeper clinical wrap than transactional telehealth
- ✓$199/month program fee is competitive; medication co-pay can drop to ~$25/month with insurance and a manufacturer savings card
- ✓Branded GLP-1s only (Wegovy, Ozempic, Zepbound, Foundayo) — no compounded products
- ✓Insurance navigation team works to maximize coverage and reportedly accepts most major commercial plans
- ✓Money-back guarantee tied to a 10% weight-loss outcome over the program year
- ✓Publishes 3-year outcomes data (19% mean weight loss)
Cons
- ✗Medication cost is on top of the $199/month fee; cash-pay patients face full manufacturer pricing
- ✗Insurance navigation only helps if your plan actually covers branded GLP-1s for weight loss — many don't
- ✗Meaningfully more expensive than compounded telehealth if your insurance denies coverage
- ✗Distinct from 'Oxford's Medical Weight Loss (The Calibrate Clinic)' — don't confuse the two
- ✗Initial 3-month commitment required ($597 total, billed as $199/mo) before it renews month-to-month — more lock-in than month-to-month rivals
How to choose an oral GLP-1 provider
Oral GLP-1s — orforglipron (Foundayo) and oral semaglutide (Rybelsus / oral Wegovy) — trade some effectiveness for needle-free convenience. The key is getting an FDA-approved pill from a legitimate prescriber, not an OTC 'GLP-1 pill' with no evidence.
What to look for
- FDA-approved pill, not a supplement. Only orforglipron and oral semaglutide are real oral GLP-1 medications. 'GLP-1 support' supplements sold over the counter are not GLP-1 drugs — make sure you're getting the prescription product.
- Know the dosing rules. Oral semaglutide must be taken on an empty stomach with strict water timing; orforglipron has no food restrictions. Pick the one that fits your routine, and confirm the provider explains the protocol.
- Pill vs. injection honesty. A good provider will tell you injections generally produce more weight loss. If a pill is being oversold as equal to or better than injectables, be skeptical.
Red flags to avoid
- No named pharmacy or LegitScript listing. A legitimate compounded-GLP-1 provider names its 503A/503B pharmacy partner and carries LegitScript certification. If neither is disclosed, you can't verify what you're injecting.
- Async-only, no real clinician review. A prescriber should review your intake and be reachable for dose questions. Instant approval with no way to reach a clinician is a safety gap.
- Teaser pricing that hides the real cost. A low 'first month' price that jumps at higher doses, or a membership fee stacked on top of the medication, can double the true monthly total. Confirm the ongoing, all-in price before you pay.
- Weight-loss claims for B12, MIC, or HCG shots. Only GLP-1 injections have trial evidence for weight loss. A clinic selling B12, lipotropic, or HCG shots as a weight-loss treatment is a red flag.
Every provider ranked above is scored against these criteria across our six-dimension methodology, and prices are re-verified against each provider’s live site.
How we rank & what counts as “legit”
Every provider in this ranking is scored against our published six-factor rubric[1] — value, effectiveness, user experience, trust & safety, accessibility, and support.
Brand-name Wegovy, Zepbound, Ozempic, and Mounjaro are separately FDA-approved under their own NDA numbers[4][5]. Published Phase 3 efficacy for semaglutide 2.4 mg (~14.9% mean weight loss over 68 weeks) comes from the STEP 1 trial[6], and for tirzepatide (~20.9% at the 15 mg dose over 72 weeks) from SURMOUNT-1[7]; the SURMOUNT-5 head-to-head published in 2025 compared the two directly[8].
Insurance coverage for anti-obesity medications varies widely by state Medicaid program and commercial plan[9][10]. Compounded and brand-name GLP-1s are generally FSA/HSA eligible with a prescription under IRS Publication 502[11].
Frequently Asked Questions
Sources & methodology — as of August 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 5.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 8.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
- 9.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 10.CMS — Medicaid prescription drug coverage policy (state-by-state)— Centers for Medicare & Medicaid Services.
- 11.IRS Publication 502 — Medical and Dental Expenses (HSA/FSA eligibility)— Internal Revenue Service.